** Brokerage BMO Capital Markets raises price target on agrichemicals company Corteva CTVA.N to $86 from $74
** The new price target represents a nearly 10% upside to the stock's last close
** "We think the stock can continue to work as current attractive multiples keep getting rolled forward on a strong growth profile," - BMO says
** Brokerage adds CTVA can push over $90/shr if the company hits its 2027 EBITDA guidance range midpoint of $4.4 billion
** Shares of CTVA marginally down at $76.35 premarket
** 18 of 25 brokerages rate the stock "buy" or higher, and seven rate it "hold"; their median PT is $75.50 - LSEG Data
** As of last close, CTVA stock is up over 34% YTD
(Reporting by Vallari Srivastava in Bengaluru)
((Srivastava.Vallari@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。